后抗生素时代单纯性尿路感染的管理:若干非抗生素方法
本文为叙述性综述,检索PubMed、Google Scholar和clinicaltrials.gov的英文临床试验,聚焦草药提取物、抗菌策略(噬菌体疗法、D-甘露糖)及非甾体抗炎药等非抗生素方法治疗单纯性尿路感染。非抗生素策略在临床试验中结果不一,当前证据尚未表明其可明确替代抗生素;作者认为需权衡无培养证实的无限制抗生素使用的实际获益与风险,并需更深入了解影响尿路感染易感性的微生物与病理生理因素以分层患者。
要点
- 非抗生素治疗尿路感染在临床试验中结果不一,当前证据尚未表明有明确更好的抗生素替代方案。
- 作者认为需权衡无培养证实的无限制抗生素使用在单纯性尿路感染中的实际获益与风险。
- 作者认为需更深入了解影响尿路感染易感性的微生物与病理生理因素及预后指标以分层最可能获益患者。
核心结论
- 非抗生素治疗尿路感染的策略在临床试验中结果不一,当前证据尚未表明有明确更好的抗生素替代方案。
- 作者认为,非抗生素治疗的集体经验提示需权衡无培养证实的无限制抗生素使用在单纯性尿路感染中的实际获益与风险。
- 作者认为,鉴于所提替代方案作用机制不同,亟需更深入了解影响尿路感染易感性的微生物与病理生理因素及预后指标,以分层最可能获益的患者。
- 作者认为,还应考虑替代方案在临床实践中的可行性。
研究设计与样本
- 叙述性综述,检索PubMed、Google Scholar和clinicaltrials.gov中与尿路感染非抗生素治疗对应的英文临床试验。
主要发现
- 综述聚焦基于草药提取物或抗菌策略(如噬菌体疗法和D-甘露糖)的有限几种非抗生素治疗尿路感染的方法。
- 非甾体抗炎药的治疗经验也被用于讨论无抗生素情况下发生肾盂肾炎的风险,并与继续广泛使用非甾体抗炎药的预期危害相比较。
- 非抗生素治疗尿路感染的策略在临床试验中结果不一,当前证据尚未表明有明确更好的抗生素替代方案。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Given the high frequency of patients presenting with urinary tract infections (UTIs) and the ensuing high degree of antibiotic prescription, UTI is a critical point of intervention for non-antibiotic treatments to curb the further development of antimicrobial resistance and provide risk-appropriate care for patients. OBJECTIVES: To highlight several select non-antibiotic therapies for the treatment of uncomplicated UTI and relevant indications (prevention and complicated UTI) from recent literature. SOURCES: PubMed, Google Scholar, and clinicaltrials.gov were searched for clinical trials published in the English language corresponding to non-antibiotic treatments for UTI. CONTENT: The focus of this narrative review centres on a limited number of non-antibiotic therapies for the treatment of UTI based on (a) herbal extracts or (b) antibacterial strategies (e.g. bacteriophage therapy and D-mannose). The experience of treatment with non-steroidal anti-inflammatory drugs is also used to fuel discussion on the risk of developing pyelonephritis without antibiotics-compared with the projected harms of continuing their widespread use. IMPLICATIONS: Non-antibiotic treatment strategies for UTI have shown varying results in clinical trials, and the current evidence does not yet indicate a clear, better alternative to antibiotics. However, the collective experience with non-antibiotic treatments suggests that there is a need to weigh the actual benefits/risks of unfettered, non-culture-confirmed antibiotic use in uncomplicated UTI. Given the different mechanisms of action of proposed alternatives, more in-depth knowledge on microbiological and pathophysiological factors influencing UTI susceptibility and prognostic indicators are highly needed to stratify patients most likely to benefit. The feasibility of alternatives in clinical practice should also be considered.
引用
- McCallin S, Kessler TM, Leitner L, et al. Management of uncomplicated urinary tract infection in the post-antibiotic era: select non-antibiotic approaches. Clin Microbiol Infect. 2023. PMID: 37301438. doi:10.1016/j.cmi.2023.06.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。